KCNA1 and episodic ataxia type 1: These in vitro findings suggest that similar functional alterations may occur in the brain of EA1 patients where Kv1.1, Kv1.2 and Kv1.4 subunits likely co-assemble and Zn2+ is released, recapitulating different clinical phenotypes.